These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 192804)

  • 1. Suppressed response to interferon inducation in mice infected with encephalomyocarditis virus, Semliki forest virus, influenza A2 virus, Herpesvirus hominis type 2, or murine cytomegalovirus.
    Stringfellow DA; Kern ER; Kelsey DK; Glasgow LA
    J Infect Dis; 1977 Apr; 135(4):540-51. PubMed ID: 192804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyporeactivity to interferon induction: characterization of a hyporeactive factor in the serum of encephalomyocarditis virus-infected mice.
    Stringfellow DA
    Infect Immun; 1975 Feb; 11(2):294-302. PubMed ID: 234407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyporeactivity due to infection: recognition of a transferable hyporeactive factor in the serum of encephalomyocarditis virus-infected mice.
    Stringfellow DA; Glasgow LA
    Infect Immun; 1974 Dec; 10(6):1337-42. PubMed ID: 4373396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyporeactivity of infection: potential limitation to therapeutic use of interferon-inducing agents.
    Stringfellow DA; Glasgow LA
    Infect Immun; 1972 Nov; 6(5):743-7. PubMed ID: 4344367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin restoration of the interferon response of hyporeactive animals.
    Stringfellow DA
    Science; 1978 Jul; 201(4353):376-8. PubMed ID: 208154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antilymphocytic serum on circulating interferon in mice as a function of the inducer.
    de Maeyer-Guignard J; de Maeyer E
    Nat New Biol; 1971 Feb; 229(7):212-4. PubMed ID: 4325471
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparation interferon- inducing and antiviral properties of 2-amino-5-bromo-6-methyl-4-pyrimidinol (U-25,166), tilorone hydrochloride, and polyinosinic-polycytidylic acid.
    Stringfellow DA
    Antimicrob Agents Chemother; 1977 Jun; 11(6):984-92. PubMed ID: 879763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of BL-3849A, a low-molecular-weight oral interferon inducer.
    Kern ER; Hamilton JR; Overall JC; Glasgow LA
    Antimicrob Agents Chemother; 1976 Oct; 10(4):691-6. PubMed ID: 185953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-viral activity of single-stranded homopolynucleotides against encephalomyocarditis virus and Semliki Forest virus in adult mice without interferon induction.
    Stebbing N; Grantham CA; Carey NH
    J Gen Virol; 1976 Jan; 30(1):21-39. PubMed ID: 173799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic interference between different enveloped RNA viruses.
    Rott R; Scholtissek C; Klenk HD; Kaluza G
    J Gen Virol; 1972 Dec; 17(3):255-64. PubMed ID: 4346650
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon inducers in therapy of infection with encephalomyocarditis virus in mice. I. Effect of single doses of polyriboinosinic-polyribocytidylic acid and tilorone hydrochloride on viral pathogenesis.
    Stringfellow DA; Overall JC; Glasgow LA
    J Infect Dis; 1974 Nov; 130(5):470-80. PubMed ID: 4371528
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of intracranial alphavirus infections in mice by a combination of specific antibodies and an interferon inducer.
    Coppenhaver DH; Singh IP; Sarzotti M; Levy HB; Baron S
    Am J Trop Med Hyg; 1995 Jan; 52(1):34-40. PubMed ID: 7531956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation of host resistance to experimental viral infections in mice: effects of Corynebacterium acnes, Corynebacterium parvum, and Bacille calmette-guérin.
    Glasgow LA; Fischbach J; Bryant SM; Kern ER
    J Infect Dis; 1977 May; 135(5):763-70. PubMed ID: 192811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of interferon-producing macrophages: new approach to viral chemotherapy.
    Glasgow LA
    Science; 1970 Nov; 170(3960):854-6. PubMed ID: 4319682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral replication and interferon production in fetal and adult ovine leukocytes and spleen cells.
    Rinaldo CR; Overall JC; Glasgow LA
    Infect Immun; 1975 Nov; 12(5):1070-7. PubMed ID: 172452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of delayed-type hypersensitivity and induction of interferon by the lipophilic agents DDA and CP-20,961.
    Kraaijeveld CA; Snippe H; Harmsen T; Benaissa-Trouw B
    Cell Immunol; 1982 Dec; 74(2):277-83. PubMed ID: 6187475
    [No Abstract]   [Full Text] [Related]  

  • 17. Physical dependence to morphine diminishes the interferon response in mice.
    Lorenzo P; Portolés A; Beneit JV; Ronda E; Portolés A
    Immunopharmacology; 1987; 14(2):93-9. PubMed ID: 2448267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycoplasma-mediated hyporeactivity to various interferon inducers.
    Cole BC; Overall JC; Lombardi PS; Glasgow LA
    Infect Immun; 1975 Dec; 12(6):1349-54. PubMed ID: 1205616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleic acid as interferon inducer. Its antiviral and antitumor activity.
    Feldmane G; Loza V; Duks A; Yesyacova I; Vinkele R; Buike A; Meldrajs J; Erele I
    Arch Immunol Ther Exp (Warsz); 1977; 25(5):693-700. PubMed ID: 202217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of liposomal charge on the neutralizing antibody response against inactivated encephalomyocarditis and Semliki Forest viruses.
    Kraaijeveld CA; Schilham M; Jansen J; Benaissa-Trouw B; Harmsen M; van Houte AJ; Snippe H
    Clin Exp Immunol; 1984 Jun; 56(3):509-14. PubMed ID: 6086188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.